{"id":"W2995117328","doi":"10.1055/s-0039-3400302","title":"Broadening the Categories of Patients Eligible for Extended Venous Thromboembolism Treatment","year":2019,"lang":"en","type":"review","venue":"Thrombosis and Haemostasis","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"Bayer","keywords":"Medicine; Apixaban; Rivaroxaban; Edoxaban; Dabigatran; Risk factor; Venous thromboembolism; Intensive care medicine; Dosing; Anticoagulant; Vitamin K antagonist; Risk assessment; Internal medicine; Warfarin; Thrombosis; Atrial fibrillation","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001828544,0.0003959253,0.0007590204,0.001308277,0.0007088775,0.001585665,0.0008724395,0.0009171077,0.01000379],"category_scores_gemma":[0.005549051,0.0001063553,0.001211835,0.001239325,0.0005093426,0.0009263261,0.002124664,0.001535438,0.002063058],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007335736,"about_ca_system_score_gemma":0.001431669,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001540349,"about_ca_topic_score_gemma":0.001470704,"domain_scores_codex":[0.9974096,0.0006859296,0.0004550725,0.0003136234,0.0005782001,0.000557584],"domain_scores_gemma":[0.9975364,0.0005700349,0.0004975899,0.0001434497,0.0005334581,0.0007191157],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.005096864,0.0007610426,0.4741255,0.00142473,0.0002978604,0.002255779,0.003064819,0.00212748,0.005033527,0.02041932,0.04276808,0.442625],"study_design_scores_gemma":[0.0006095377,0.002254491,0.7012142,0.003450942,0.0006224305,0.009329787,0.005978166,0.005704809,0.002052855,0.02969717,0.2388817,0.0002038639],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"review","genre_scores_codex":[0.7869003,0.03938424,0.02594685,0.01927761,0.001983265,0.00256541,0.009094194,0.0004155053,0.1144325],"genre_scores_gemma":[0.9637076,0.006923659,0.008403073,0.006083118,0.001270068,0.001349214,0.006391316,0.0001007953,0.005771278],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.01000379,"threshold_uncertainty_score":0.03346598,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1454726372054561,"score_gpt":0.3973808184656452,"score_spread":0.251908181260189,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}